Health inspection·August 31, 2023

F 0656 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Develop and implement a complete care plan that meets all the resident's needs, with timetables and actions that can be measured. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review the facility failed to develop and implement a comprehensive person-centered care plan that includes measurable objectives and time frames to meet a resident's medical and nursing needs to be furnished to attain or maintain the resident's highest practicable physical, mental, and psychosocial well-being for 1 of 8 residents, Resident #105 (R #105), reviewed for care plans in that: The facility failed to develop a comprehensive person-centered care plan for R #105, use of anticoagulant medication. This deficient practices could place residents in the facility at risk of not being provided with the necessary care or services and having personalized plans developed to address their specific needs. The findings: Record review of R #105's Face Sheet revealed an [AGE] year-old female, with an original admission date of 12/22/2022. Diagnoses included, Type 2 diabetes (insufficient production of insulin in the body), Atherosclerotic Heart Disease (arteries become narrowed and hardened due to buildup of plaque (fats) in the artery wall), and cardiac pacemaker (small battery powered device that prevents the heart from beating too slowly), and Hypertension (high blood pressure). Record review of R #105's Quarterly Minimum Data Set, dated [DATE] revealed R #105 had a BIMS (Brief Interview Mental Status) of 06 (Severe Impairment) and requires Extensive Assistance with transfers and limited assistance with bed mobility, eating, toilet use, dressing, and personal hygiene. Record review of R #105's Care Plan dated 8/17/2023 revealed no care plan for anticoagulants. Record review of R #105's MDS had no indication of anticoagulant use. Record review of R #105's orders stated; -Clopidogrel Bisulfate Tablet 75 MG Give 1 tablet by mouth one time a day for blood clot prevention dated 6/29/2023 -Anticoagulant Medication Side Effect Monitoring- Code the following if identified:0-None, 1- Discolored Urine, 2- Black Tarry Stools, 3- Sudden Severe Headache, 4- N&V (nausea and vomitting), 5(continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 676465 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 676465 B. Wing A. Building (X3) DATE SURVEY COMPLETED 08/31/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Las Alturas Nursing & Transitional Care 4301 North Bartlett Avenue Laredo, TX 78041 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)